Click on image to view larger version.

Figure 2 Kaplan-Meier Plots of Cumulative Events up to 2 Years for "On-Label" and "Off-Label" BMS and DES Indications

The number of patients at risk for each follow-up period is given below the graph. All adverse outcomes were lower with DES than with BMS for both "on-label" and "off-label" indications, and event rates were lower for "on-label" compared with "off-label" indications regardless of stent type. Abbreviations as in Figure 1.